HLOSF

HEALIOS K K by HEALIOS K K (HLOSF)

About HEALIOS K K by HEALIOS K K (HLOSF)

Healios KK engages in the research, development, and sale of cellular and regenerative medicine. It develops therapies for ischemic stroke, acute respiratory distress syndrome, liver disease, and age-regulated macular degeneration. The company was founded by Tadahisa Kagimoto on February 24, 2011 and is headquartered in Tokyo, Japan.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$3.44
52 Week Low
$0.96
Market cap
359.6M
Dividend yield
0.00%
Volume
--
Avg. volume
17
P/E ratio
-11.13

HEALIOS K K by HEALIOS K K News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$3.44
52 Week Low
$0.96
Market cap
359.6M
Dividend yield
0.00%
Volume
--
Avg. volume
17
P/E ratio
-11.13